Evidence map›Paper›PMID 35747051›Full record

ArticleCureus2022

Reversible Autoimmune Cardiomyopathy Secondary to a Vaccine-Induced Multisystem Inflammatory Syndrome.

Ana P Urena Neme, Elmer R De Camps Martinez, Constangela Matos Noboa, Miguel A Rodriguez Guerra, Pedro Ureña

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ana P Urena NemeCardiology, Medicina Cardiovascular Asociada, Distrito Nacional, DOM.
Elmer R De Camps MartinezCardiology, Medicina Cardiovascular Asociada, Distrito Nacional, DOM.
Constangela Matos NoboaCardiology, Medicina Cardiovascular Asociada, Distrito Nacional, DOM.
Miguel A Rodriguez GuerraMedicine, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, USA.
Pedro UreñaInterventional Cardiology, Medicina Cardiovascular Asociada, Distrito Nacional, DOM.
Albert Einstein College of Medicine · USSociety of Interventional Radiology · USUniversidad Instituto Nacional de Ciencias Exactas · DO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Dominican government started an early booster protocol, including a heterogeneous vaccination sequence needed based on availability. We report a case of a 25-year-old male who presented with jaundice, and vomiting for 6 days, associated with maculopapular rash (Mucocutaneous features), elevated pro-B-type natriuretic peptide (pro-BNP), erythrocyte sedimentation rate (ESR), transaminitis (> 1000 U/L), thrombocytopenia, echocardiogram evidenced stigmata of heart failure after his third dose of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. He was started on steroids and immunoglobulin therapy for multisystemic organ failure syndrome. A significant improvement was noticed, then was discharge; in the post-discharge clinic, he was asymptomatic, inflammatory markers improved, and the echocardiogram showed a recovered ejection fraction. An accurate anamnesis, including a proper chronologic gathering of the events, is essential to recognize a vaccine-multisystem inflammatory syndrome; its prompt assessment and therapy would directly improve the outcome.

Indexed as

covid vaccination boostermultisystem inflammatory syndrome by vaccination (mis-v)multisystem inflammatory syndrome (mis)reversible autoimmune cardiomyopathysars-cov-2

Identifiers

PMID35747051
PMCPMC9206861
OpenAlexW4280567881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.